Current Events Prove the Value-Based Reimbursement Summit Is a Can’t-Miss Event!
Friday September 8th, 2017
Since the release of the brochure for ExL‘s Value-Based Strategies for Reimbursement and Formulary Success, recent news has emerged, highlighting the pressure placed on life science organizations to account for the healthcare value of drugs in reimbursement strategies. In an era of performance-driven healthcare, we have continued to follow this topic in the news. The below articles address current events in formulary access and reimbursement strategies and highlight the importance of staying up to date with industry developments.
Will the UK’s Post-Brexit Life Sciences Strategy Be a Boon for Market Access?
The highly anticipated life sciences strategy commissioned by the UK government has finally been released and addresses different strategies to boost the uptake of innovative medicines and approaches to pricing. Read more about what we can learn from the UK’s strategy here.
Are Drugs Too Expensive “at Any Price”?
As threats continue against the Affordable Care Act, experts discuss how a repeal and replacement could suggest new inequalities to healthcare by expensive new drugs, which test the limits of insurance reimbursement. Read the full discussion here.
One in Twelve Doctors Accepts Payment From Pharmaceutical Companies Related to Opioids
CMS identified 375,255 non-research, opioid-related payments to 68,177 physicians totaling over $46 million in two years. ScienceDaily examines how prescribing patterns are influenced by life science organizations here.
Pharmaceutical Spending Surging Over Five-Year Period
A recently published study documents a fourfold growth in pharmaceutical spending at Boston Children’s Hospital that is attributed to drug policies, shortages, and regulatory issues. Read the entire article here.
Join your industry peers at the Value-Based Strategies for Reimbursement and Formulary Success on November 6–7 in Bethesda, MD. Register today to take advantage of our Early Bird pricing — a $200 savings!
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs